Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene

Clin Endocrinol (Oxf). 2006 Dec;65(6):816-25. doi: 10.1111/j.1365-2265.2006.02673.x.

Abstract

Objective: We previously described an association between the -344C/T 5'-untranslated region (UTR) polymorphism in the CYP11B2 (aldosterone synthase) gene and hypertension with a raised aldosterone to renin ratio (ARR); the same genetic variant is also associated with impaired adrenal 11beta-hydroxylase efficiency. The -344 polymorphism does not seem to be functional, so is likely to be in linkage with variants in CYP11B1 that determine the associated variation in 11beta-hydroxylase efficiency. We therefore aimed to determine whether there is an association between CYP11B1 variants and hypertension and/or an altered ARR.

Design and measurements: We screened 160 subjects divided into four groups, normotensive controls, unselected hypertensive subjects, and hypertensive subjects with either a high (> or = 750) or low ARR (< or = 200), for variants in the coding region of CYP11B1 by single-stranded conformation polymorphism (SSCP) and direct sequencing. The effects of these variants on enzyme function were assessed by conversion of 11-deoxycortisol to cortisol and 11-deoxycorticosterone (DOC) to corticosterone.

Results: Eight novel missense mutations were identified in the CYP11B1 gene that alter the encoded amino acids: R43Q, L83S, H125R, P135S, F139L, L158P, L186V and T196A. In each case they were heterozygous changes. However, no mutations were identified that could account for hypertension and/or a raised ARR. The variants L158P and L83S severely impaired enzyme function while R43Q, F139L, P135S and T196A enzymes resulted in product levels that were approximately 30-50% that of wild-type levels. The variant enzymes H125R and L186V resulted in substrate-specific alterations in enzyme function. H125R decreased conversion of 11-deoxycortisol to cortisol and L186V increased 11-deoxycortisol conversion. Neither had an effect on the conversion of DOC to corticosterone.

Conclusion: No variants were identified in the coding region of CYP11B1 that could account for hypertension and/or a raised ARR. However, this in vitro study identifies the importance of these affected residues to enzyme function and will inform subsequent studies of structure-function relationships.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aldosterone / metabolism
  • Animals
  • Biological Assay / methods
  • Case-Control Studies
  • Corticosterone / metabolism
  • Cortodoxone / metabolism
  • Desoxycorticosterone / metabolism
  • Humans
  • Hydrocortisone / metabolism
  • Hyperaldosteronism / complications
  • Hyperaldosteronism / genetics
  • Hyperaldosteronism / metabolism*
  • Hypertension / complications
  • Hypertension / genetics
  • Hypertension / metabolism*
  • Middle Aged
  • Mutation, Missense*
  • Polymorphism, Single Nucleotide
  • Rats
  • Renin / metabolism
  • Sequence Analysis, DNA
  • Steroid 11-beta-Hydroxylase / genetics*
  • Steroid 11-beta-Hydroxylase / metabolism*

Substances

  • Desoxycorticosterone
  • Aldosterone
  • Steroid 11-beta-Hydroxylase
  • Renin
  • Corticosterone
  • Cortodoxone
  • Hydrocortisone